285 related articles for article (PubMed ID: 8910635)
1. Endometrial stromal sarcoma: analysis of treatment failures and survival.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Urgesi A; Lissoni A; Losa G; Fanucchi A
Gynecol Oncol; 1996 Nov; 63(2):247-53. PubMed ID: 8910635
[TBL] [Abstract][Full Text] [Related]
2. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
[TBL] [Abstract][Full Text] [Related]
3. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
[TBL] [Abstract][Full Text] [Related]
4. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
5. Uterine leiomyosarcoma: analysis of treatment failures and survival.
Gadducci A; Landoni F; Sartori E; Zola P; Maggino T; Lissoni A; Bazzurini L; Arisio R; Romagnolo C; Cristofani R
Gynecol Oncol; 1996 Jul; 62(1):25-32. PubMed ID: 8690287
[TBL] [Abstract][Full Text] [Related]
6. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
7. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
8. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
[TBL] [Abstract][Full Text] [Related]
9. A multi-institutional review of outcomes of endometrial stromal sarcoma.
Leath CA; Huh WK; Hyde J; Cohn DE; Resnick KE; Taylor NP; Powell MA; Mutch DG; Bradley WH; Geller MA; Argenta PA; Gold MA
Gynecol Oncol; 2007 Jun; 105(3):630-4. PubMed ID: 17320937
[TBL] [Abstract][Full Text] [Related]
10. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
11. Primary extrauterine endometrial stromal neoplasms: a clinicopathologic study of 20 cases and a review of the literature.
Chang KL; Crabtree GS; Lim-Tan SK; Kempson RL; Hendrickson MR
Int J Gynecol Pathol; 1993 Oct; 12(4):282-96. PubMed ID: 8253545
[TBL] [Abstract][Full Text] [Related]
12. Low-grade endometrial stromal sarcoma with inferior vena cava tumor thrombus and intracardiac extension: radical resection may improve recurrence free survival.
Renzulli P; Weimann R; Barras JP; Carrel TP; Candinas D
Surg Oncol; 2009 Mar; 18(1):57-64. PubMed ID: 18708288
[TBL] [Abstract][Full Text] [Related]
13. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
14. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
15. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
Weitmann HD; Kucera H; Knocke TH; Pötter R
Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
[TBL] [Abstract][Full Text] [Related]
16. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma.
Shah JP; Bryant CS; Kumar S; Ali-Fehmi R; Malone JM; Morris RT
Obstet Gynecol; 2008 Nov; 112(5):1102-8. PubMed ID: 18978112
[TBL] [Abstract][Full Text] [Related]
17. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].
Ma SK; Zhang HT; Wu LY; Liu LY; Li B
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701
[TBL] [Abstract][Full Text] [Related]
18. Analysis of FIGO Stage IIIc endometrial cancer patients.
McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
[TBL] [Abstract][Full Text] [Related]
19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
20. [Clinical review of 97 patients with endometrial stromal sarcoma].
Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):115-9. PubMed ID: 18683750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
